Compare Procter & Gamble Health with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs UNICHEM LAB - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH UNICHEM LAB PROCTER & GAMBLE HEALTH/
UNICHEM LAB
 
P/E (TTM) x 18.1 -49.0 - View Chart
P/BV x 7.3 1.2 604.9% View Chart
Dividend Yield % 6.5 1.2 566.1%  

Financials

 PROCTER & GAMBLE HEALTH   UNICHEM LAB
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
UNICHEM LAB
Mar-19
PROCTER & GAMBLE HEALTH/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs3,549292 1,215.4%   
Low Rs1,301182 715.0%   
Sales per share (Unadj.) Rs511.4167.7 305.0%  
Earnings per share (Unadj.) Rs61.3-3.6 -1,688.1%  
Cash flow per share (Unadj.) Rs74.05.9 1,245.7%  
Dividends per share (Unadj.) Rs440.004.00 11,000.0%  
Dividend yield (eoy) %18.11.7 1,075.0%  
Book value per share (Unadj.) Rs927.8372.3 249.2%  
Shares outstanding (eoy) m16.6070.38 23.6%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.71.4 335.5%   
Avg P/E ratio x39.6-65.3 -60.6%  
P/CF ratio (eoy) x32.839.9 82.1%  
Price / Book Value ratio x2.60.6 410.6%  
Dividend payout %717.9-110.2 -651.6%   
Avg Mkt Cap Rs m40,25716,680 241.4%   
No. of employees `0001.12.6 43.6%   
Total wages/salary Rs m1,3132,393 54.9%   
Avg. sales/employee Rs Th7,486.74,535.2 165.1%   
Avg. wages/employee Rs Th1,157.6919.8 125.9%   
Avg. net profit/employee Rs Th897.2-98.2 -913.6%   
INCOME DATA
Net Sales Rs m8,49011,801 71.9%  
Other income Rs m244984 24.8%   
Total revenues Rs m8,73412,785 68.3%   
Gross profit Rs m1,482-835 -177.5%  
Depreciation Rs m211674 31.3%   
Interest Rs m075 0.0%   
Profit before tax Rs m1,514-600 -252.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m660-   
Tax Rs m563-343 -163.8%   
Profit after tax Rs m1,017-256 -398.2%  
Gross profit margin %17.5-7.1 -246.7%  
Effective tax rate %37.157.3 64.9%   
Net profit margin %12.0-2.2 -553.4%  
BALANCE SHEET DATA
Current assets Rs m15,34320,384 75.3%   
Current liabilities Rs m1,9605,029 39.0%   
Net working cap to sales %157.6130.1 121.1%  
Current ratio x7.84.1 193.1%  
Inventory Days Days49105 46.5%  
Debtors Days Days28135 21.1%  
Net fixed assets Rs m1,2099,023 13.4%   
Share capital Rs m166141 117.9%   
"Free" reserves Rs m15,23526,058 58.5%   
Net worth Rs m15,40126,199 58.8%   
Long term debt Rs m00-   
Total assets Rs m17,59531,496 55.9%  
Interest coverage xNM-7.0-  
Debt to equity ratio x00-  
Sales to assets ratio x0.50.4 128.8%   
Return on assets %5.8-0.6 -1,010.0%  
Return on equity %6.6-1.0 -677.3%  
Return on capital %10.3-2.0 -513.1%  
Exports to sales %069.4 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA8,188 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,6368,188 20.0%   
Fx outflow Rs m4,368596 732.9%   
Net fx Rs m-2,7327,592 -36.0%   
CASH FLOW
From Operations Rs m-1,304-3,278 39.8%  
From Investments Rs m12,697-2,860 -443.9%  
From Financial Activity Rs m-301-24 1,241.7%  
Net Cashflow Rs m11,093-4,690 -236.5%  

Share Holding

Indian Promoters % 0.0 50.1 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 15.1 120.5%  
FIIs % 1.0 3.0 33.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 31.7 91.8%  
Shareholders   28,591 20,176 141.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   FDC  ALEMBIC  WYETH  AJANTA PHARMA  SUVEN LIFE SCIENCES  

Compare PROCTER & GAMBLE HEALTH With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 441 Points Lower; Nifty Settles Below 15,000-Mark(Closing)

Indian share markets witnessed huge selling during closing hours today and ended their day lower.

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY21); Net Profit Up 57.0% (Quarterly Result Update)

Aug 31, 2020 | Updated on Aug 31, 2020

For the quarter ended June 2020, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 692 m (up 57.0% YoY). Sales on the other hand came in at Rs 6 bn (up 171.6% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

How Much Money For Day Trading?(Fast Profits Daily)

Feb 22, 2021

In this video, I'll show you how to allocate your capital as a day trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Mar 5, 2021 03:32 PM

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - PFIZER COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS